Shares of Tiziana Life Sciences Ltd. (TLSA) touched a 52-week high of $1.91 last week, marking a remarkable year-to-date increase of more than 170%.This biotechnology company is focused on immunomodulation therapies for neuroinflammatory and neurodegenerative diseases, and its lead development candidate is intranasal Foralumab, a fully human, anti-CD3 monoclonal antibody.Foralumab works by binding...
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.